Eltek (NASDAQ:ELTK) reported a wider loss for the second quarter of 2026 as production inefficiencies, lower revenue volume and currency pressures weighed on profitability, even as management said demand and backlog remained strong.
Revenue totaled $11.5 million for the quarter, down from $12.5 mil
Eltek (NASDAQ:ELTK) reported a sharp year-over-year decline in first-quarter 2026 results, with management attributing the weaker performance to backlog timing, logistics constraints, raw-material shortages and foreign exchange pressure rather than a change in underlying demand.
Chief Executive Off
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also fell, dropping, 0.14% to 5,116.66.
U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&P 500 also fell, dropping, 0.27% to 5,110.11.
U.S. stocks traded lower this morning, with the Dow Jones index dipping around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.27% to 38,618.51 while the NASDAQ fell 0.16% to 16,058.93. The S&P 500 also fell, dropping, 0.24% to 5,111.38.
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
Companies Reporting Before The Bell • Children's Place (NASDAQ:PLCE) is projected to report quarterly earnings at $3.56 per share on revenue of $471.82 million.
